Search tips
Search criteria 


Logo of brmedjLink to Publisher's site
Br Med J. 1978 August 5; 2(6134): 385–388.
PMCID: PMC1609020

Need for beta-blockade in hypertension reduced with long-term minoxidil.


Sequential changes in plasma renin activity and urinary aldosterone and noradrenaline were assessed in eight patients with severe hypertension after minoxidil had been added to their treatment. Doses of 2.5--27.5 (mean 12.5) mg/day reduced the mean blood pressure from 166/113 +/-6/2 mm Hg to 124/88+/-4/2 mm Hg in one week. Plasma renin activity and urinary aldosterone and noradrenaline increased twofold to threefold initially but returned to baseline values within two to three weeks and remained unchanged during a mean follow-up of 5.1 months. Beta-blocking drugs were then withdrawn slowly in six patients without adverse effects, though blood pressure and heart rate increased in three patients, who required minimal doses of beta-blockers. Plasma renin activity and urinary aldosterone and noradrenaline did not change significantly after beta-blockade had been stopped. We conclude that the need for beta-blockade is greatly reduced with long-term minoxidil treatment and that it may be unnecessary in some patients.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (852K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Gilmore E, Weil J, Chidsey C. Treatment of essential hypertension with a new vasodilator in combination with beta-adrenergic blockade. N Engl J Med. 1970 Mar 5;282(10):521–527. [PubMed]
  • Koch-Weser J. Vasodilator drugs in the treatment of hypertension. Arch Intern Med. 1974 Jun;133(6):1017–1027. [PubMed]
  • Gottlieb TB, Katz FH, Chidsey CA., 3rd Combined therapy with vasodilator drugs and beta-adrenergic blockade in hypertension. A comparative study of minoxidil and hydralazine. Circulation. 1972 Mar;45(3):571–582. [PubMed]
  • Limas CJ, Freis ED. Minoxidil in severe hypertension with renal failure. Effect of its addition to conventional antihypertensive drugs. Am J Cardiol. 1973 Mar;31(3):355–361. [PubMed]
  • O'Malley K, Velasco M, Wells J, McNay JL. Control plasma renin activity and changes in sympathetic tone as determinants of minoxidil-induced increase in plasma renin activity. J Clin Invest. 1975 Feb;55(2):230–235. [PMC free article] [PubMed]
  • Ueda H, Yagi S, Kaneko Y. Hydralazine and plasma renin activity. Arch Intern Med. 1968 Nov;122(5):387–391. [PubMed]
  • Küchel O, Fishman LM, Liddle GW, Michelakis A. Effect of diazoxide on plasma renin activity in hypertensive patients. Ann Intern Med. 1967 Oct;67(4):791–799. [PubMed]
  • Sealey JE, Gerten-Banes J, Laragh JH. The renin system: Variations in man measured by radioimmunoassay or bioassay. Kidney Int. 1972 Apr;1(4):240–253. [PubMed]
  • Sealey JE, Bühler FR, Laragh JH, Manning EL, Brunner HR. Aldosterone excretion. Physiological variations in man measured by radioimmunoassay or double-isotope dilution. Circ Res. 1972 Sep;31(3):367–378. [PubMed]
  • Assaykeen TA, Clayton PL, Goldfien A, Ganong WF. The effect of alpha- and beta-adrenergic blocking agents on the renin response to hypoglycemia and epinephrine in dogs. Endocrinology. 1970 Dec;87(6):1318–1322. [PubMed]
  • Davis JO, Freeman RH. Mechanisms regulating renin release. Physiol Rev. 1976 Jan;56(1):1–56. [PubMed]

Articles from British Medical Journal are provided here courtesy of BMJ Publishing Group